Frontiers | N-Linked Glycosylation Regulates CD22 Organization and Function
CD22 Monoclonal Antibody (2D6), PE (MCD2204)
CD22 Antibody (D-5) | SCBT - Santa Cruz Biotechnology
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial | Nature Medicine
Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling | The EMBO Journal
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease | Nature Reviews Rheumatology
---Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-54473-img0005.jpg "Siglec-2/CD22 Antibody (BLCAM/1795) - Azide and BSA Free (NBP2-54473): Novus Biologicals")
Siglec-2/CD22 Antibody (BLCAM/1795) - Azide and BSA Free (NBP2-54473): Novus Biologicals
Cancers | Free Full-Text | CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
CD22 is a negative regulator of B-cell receptor signalling: Current Biology
Immature B Cell Marker Antibody Panel (CD19, CD20, CD22, IgM Fc) (FACS) (ARG30308) - arigo Biolaboratories
CD22/BL-CAM (B-Cell Marker) Recombinant Monoclonal Antibody (rBLCAM/6749) (933-MSM9-P1)
Recombinant Human Siglec-2/CD22 Fc Alexa Fluor® 647 Protein AFR1968-020: R&D Systems
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
Coordinated changes in glycosylation regulate the germinal center through CD22 - ScienceDirect
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR: Molecular Therapy
Expression of CD22 and CD19 B-cell precursor ALL cell lines. (A)... | Download Scientific Diagram
CD22 - an overview | ScienceDirect Topics
What Is The Cell Surface Marker- CUSABIO
The inhibitory coreceptor CD22 restores B cell signaling by developmentally regulating Cd45−/− immunodeficient B cells | Science Signaling
Molecular basis of human CD22 function and therapeutic targeting | Nature Communications
Pharmaceuticals | Free Full-Text | Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
CD22 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
